|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,282.90 INR | +0.69% |
|
+3.25% | +12.17% |
| 07-07 | India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law | RE |
| 07-06 | Glenmark Pharmaceuticals Launches Olanzapine for Injection | MT |
| Market Cap | 644B 6.75B 5.91B 5.45B 5.03B 9.55B 9.71B 65.12B 25.57B 317B 25.36B 24.81B 1,091B | P/E 2026 |
44.2x | P/E 2027 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise Value | 605B 6.34B 5.55B 5.12B 4.73B 8.97B 9.12B 61.14B 24.01B 298B 23.82B 23.3B 1,025B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.64x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.23% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +0.69% | ||
| 1 week | +3.25% | ||
| Current month | +3.57% | ||
| 1 month | +6.46% | ||
| 3 months | +5.53% | ||
| 6 months | +13.74% | ||
| Current year | +12.17% |
| 1 week | 2,212.6 |  | 2,304.1 |
| 1 month | 2,101 | | 2,304.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 671.35 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | +3.25% | +19.90% | +243.91% | 6.75B | |
| -0.17% | +1.61% | +16.42% | +85.22% | 48.69B | |
| +1.04% | -1.02% | +69.47% | +115.88% | 36.38B | |
| -0.13% | -1.29% | -2.60% | +41.58% | 12.19B | |
| -0.71% | +0.89% | +18.28% | +97.87% | 12.04B | |
| -0.76% | +0.38% | +33.16% | +123.08% | 9.04B | |
| -0.86% | +0.37% | +52.61% | -3.54% | 7.06B | |
| +0.75% | -0.82% | +17.49% | +44.79% | 7.09B | |
| +5.45% | -7.36% | -17.93% | +13.17% | 6.1B | |
| +1.24% | +0.67% | +29.22% | +138.06% | 4.38B | |
| Average | +0.65% | -0.31% | +23.60% | +90.00% | 14.97B | |
| Weighted average by Cap. | +0.37% | +0.11% | +29.81% | +92.08% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.61B 1.4B 1.3B 1.2B 2.27B 2.31B 15.48B 6.08B 75.43B 6.03B 5.9B 259B | 167B 1.75B 1.53B 1.41B 1.3B 2.47B 2.51B 16.85B 6.62B 82.13B 6.56B 6.42B 282B |
| Net income | 20.53B 215M 188M 174M 160M 304M 309M 2.08B 815M 10.11B 808M 791M 34.77B | 23.28B 244M 214M 197M 182M 345M 351M 2.35B 924M 11.47B 917M 897M 39.43B |
| Net Debt | -39.29B -412M -360M -332M -307M -583M -592M -3.97B -1.56B -19.36B -1.55B -1.51B -66.55B | -37.12B -389M -340M -314M -290M -550M -560M -3.75B -1.47B -18.29B -1.46B -1.43B -62.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | ₹2,282.90 | +0.69% | 602,305 |
| 09/07/26 | ₹2,267.20 | +1.96% | 427,091 |
| 08/07/26 | ₹2,223.70 | -1.82% | 337,287 |
| 07/07/26 | ₹2,264.90 | -0.26% | 770,737 |
| 06/07/26 | ₹2,270.90 | +2.71% | 600,450 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
